FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998633680> ?p ?o ?g. }

• W1998633680 endingPage "569" @default.
• W1998633680 startingPage "564" @default.
• W1998633680 abstract "Acute graft-versus-host disease (GvHD) is a major complication that prevents successful outcomes after allogeneic bone marrow transplantation (BMT), an effective therapy for hematological malignancies. Several studies demonstrate that donor T cells and host antigen-presenting cells along with several proinflammatory cytokines are required for the induction of GvHD and contribute to its severity. Increasing evidence demonstrates that human serum-derived αalpha-1- anti-trypsin (AAT) reduces production of proinflammatory cytokines, induces anti-inflammatory cytokines, and interferes with maturation of dendritic cells. Using well-characterized mouse models of BMT, we have studied the effects of AAT on GvHD severity. Administration of AAT early after BMT decreased mortality in three models of GvHD and reduced serum levels of proinflammatory cytokines in the allogeneic recipients compared with vehicle (albumin) treated animals. AAT treatment reduced the expansion of alloreactive T effector cells but enhanced the recovery of T regulatory T cells, (Tregs) thus altering the ratio of donor T effector to T regulatory cells in favor of reducing the pathological process. However, despite altering the ratio in vivo, AAT had no direct effects on either the donor T effector cells or T regulatory cells Tregs in vitro. In contrast, AAT suppressed LPS-induced in vitro secretion of proinflammatory cytokines such as TNF-α and IL-1β, enhanced the production of the anti-inflammatory cytokine IL-10, and impaired NF-κB translocation in the host dendritic cells. In light of its long history of safety in humans, these findings suggest that administration of AAT represents a novel unique and viable strategy to mitigate clinical GvHD." @default.
• W1998633680 created "2016-06-24" @default.
• W1998633680 creator A5001287767 @default.
• W1998633680 creator A5028234430 @default.
• W1998633680 creator A5034556171 @default.
• W1998633680 creator A5035807104 @default.
• W1998633680 creator A5038420195 @default.
• W1998633680 creator A5059680649 @default.
• W1998633680 creator A5070421475 @default.
• W1998633680 creator A5071643003 @default.
• W1998633680 creator A5078441495 @default.
• W1998633680 date "2011-12-27" @default.
• W1998633680 modified "2023-10-01" @default.
• W1998633680 title "Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation" @default.
• W1998633680 cites W1549812787 @default.
• W1998633680 cites W168858771 @default.
• W1998633680 cites W1755809809 @default.
• W1998633680 cites W1795844187 @default.
• W1998633680 cites W1896328758 @default.
• W1998633680 cites W1970127550 @default.
• W1998633680 cites W1978635205 @default.
• W1998633680 cites W1981298448 @default.
• W1998633680 cites W1992613163 @default.
• W1998633680 cites W1996223831 @default.
• W1998633680 cites W2003952091 @default.
• W1998633680 cites W2007392553 @default.
• W1998633680 cites W2009075017 @default.
• W1998633680 cites W2020672759 @default.
• W1998633680 cites W2026361605 @default.
• W1998633680 cites W2030428868 @default.
• W1998633680 cites W2032386695 @default.
• W1998633680 cites W2051277340 @default.
• W1998633680 cites W2051362315 @default.
• W1998633680 cites W2051683789 @default.
• W1998633680 cites W2054124482 @default.
• W1998633680 cites W2057099776 @default.
• W1998633680 cites W2059611756 @default.
• W1998633680 cites W2061725473 @default.
• W1998633680 cites W2064146867 @default.
• W1998633680 cites W2065781543 @default.
• W1998633680 cites W2066744262 @default.
• W1998633680 cites W2067564880 @default.
• W1998633680 cites W2067598698 @default.
• W1998633680 cites W2075326117 @default.
• W1998633680 cites W2076000587 @default.
• W1998633680 cites W2079007791 @default.
• W1998633680 cites W2084326063 @default.
• W1998633680 cites W2084644134 @default.
• W1998633680 cites W2087018289 @default.
• W1998633680 cites W2093452703 @default.
• W1998633680 cites W2116455560 @default.
• W1998633680 cites W2123076394 @default.
• W1998633680 cites W2139823699 @default.
• W1998633680 cites W2140244817 @default.
• W1998633680 cites W2144491171 @default.
• W1998633680 cites W2153838226 @default.
• W1998633680 cites W2155779547 @default.
• W1998633680 cites W2155845033 @default.
• W1998633680 cites W2157325100 @default.
• W1998633680 cites W2157979692 @default.
• W1998633680 cites W2160700813 @default.
• W1998633680 cites W2161239722 @default.
• W1998633680 cites W2165234914 @default.
• W1998633680 cites W2168576606 @default.
• W1998633680 cites W2170334907 @default.
• W1998633680 cites W4244712895 @default.
• W1998633680 doi "https://doi.org/10.1073/pnas.1117665109" @default.
• W1998633680 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3258603" @default.
• W1998633680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22203983" @default.
• W1998633680 hasPublicationYear "2011" @default.
• W1998633680 type Work @default.
• W1998633680 sameAs 1998633680 @default.
• W1998633680 citedByCount "111" @default.
• W1998633680 countsByYear W19986336802012 @default.
• W1998633680 countsByYear W19986336802013 @default.
• W1998633680 countsByYear W19986336802014 @default.
• W1998633680 countsByYear W19986336802015 @default.
• W1998633680 countsByYear W19986336802016 @default.
• W1998633680 countsByYear W19986336802017 @default.
• W1998633680 countsByYear W19986336802018 @default.
• W1998633680 countsByYear W19986336802019 @default.
• W1998633680 countsByYear W19986336802020 @default.
• W1998633680 countsByYear W19986336802021 @default.
• W1998633680 countsByYear W19986336802022 @default.
• W1998633680 countsByYear W19986336802023 @default.
• W1998633680 crossrefType "journal-article" @default.
• W1998633680 hasAuthorship W1998633680A5001287767 @default.
• W1998633680 hasAuthorship W1998633680A5028234430 @default.
• W1998633680 hasAuthorship W1998633680A5034556171 @default.
• W1998633680 hasAuthorship W1998633680A5035807104 @default.
• W1998633680 hasAuthorship W1998633680A5038420195 @default.
• W1998633680 hasAuthorship W1998633680A5059680649 @default.
• W1998633680 hasAuthorship W1998633680A5070421475 @default.
• W1998633680 hasAuthorship W1998633680A5071643003 @default.
• W1998633680 hasAuthorship W1998633680A5078441495 @default.
• W1998633680 hasBestOaLocation W19986336801 @default.
• W1998633680 hasConcept C126322002 @default.
• W1998633680 hasConcept C164027704 @default.

• next